MARAOLO, ALBERTO ENRICO
 Distribuzione geografica
Continente #
AS - Asia 4.357
NA - Nord America 3.412
EU - Europa 2.241
SA - Sud America 489
Continente sconosciuto - Info sul continente non disponibili 176
AF - Africa 89
OC - Oceania 9
Totale 10.773
Nazione #
US - Stati Uniti d'America 3.190
SG - Singapore 1.830
RU - Federazione Russa 1.098
CN - Cina 926
VN - Vietnam 672
IT - Italia 460
BR - Brasile 387
HK - Hong Kong 337
BD - Bangladesh 199
DE - Germania 131
NL - Olanda 111
CA - Canada 110
FR - Francia 107
JP - Giappone 99
GB - Regno Unito 80
KR - Corea 69
FI - Finlandia 63
IN - India 63
MX - Messico 58
AR - Argentina 38
IE - Irlanda 36
PL - Polonia 27
ZA - Sudafrica 26
ID - Indonesia 23
AT - Austria 20
IQ - Iraq 19
EC - Ecuador 18
ES - Italia 16
SE - Svezia 15
TR - Turchia 15
MA - Marocco 14
PH - Filippine 14
TH - Thailandia 14
LT - Lituania 12
TW - Taiwan 12
UA - Ucraina 12
CI - Costa d'Avorio 10
JM - Giamaica 10
UZ - Uzbekistan 9
VE - Venezuela 9
CL - Cile 8
CO - Colombia 8
CR - Costa Rica 8
TN - Tunisia 8
BE - Belgio 7
PY - Paraguay 7
SA - Arabia Saudita 7
JO - Giordania 6
NP - Nepal 6
PE - Perù 6
RO - Romania 6
AU - Australia 5
CH - Svizzera 5
EE - Estonia 5
EG - Egitto 5
KE - Kenya 5
MY - Malesia 5
PK - Pakistan 5
TT - Trinidad e Tobago 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
BO - Bolivia 4
DZ - Algeria 4
HN - Honduras 4
RS - Serbia 4
SV - El Salvador 4
UY - Uruguay 4
AZ - Azerbaigian 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
GR - Grecia 3
HU - Ungheria 3
IL - Israele 3
LB - Libano 3
LC - Santa Lucia 3
NG - Nigeria 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
OM - Oman 3
PR - Porto Rico 3
AL - Albania 2
BB - Barbados 2
CG - Congo 2
DO - Repubblica Dominicana 2
GD - Grenada 2
GE - Georgia 2
GT - Guatemala 2
PS - Palestinian Territory 2
SC - Seychelles 2
SN - Senegal 2
AD - Andorra 1
AO - Angola 1
BH - Bahrain 1
BZ - Belize 1
CM - Camerun 1
DM - Dominica 1
EU - Europa 1
GH - Ghana 1
GM - Gambi 1
Totale 10.579
Città #
Singapore 902
San Jose 629
Hong Kong 326
Hefei 324
Ashburn 294
Moscow 262
Beijing 220
Ho Chi Minh City 200
Hanoi 152
Chandler 147
Los Angeles 137
Santa Clara 133
Council Bluffs 106
The Dalles 104
New York 90
Tokyo 87
Naples 86
Lauterbourg 82
Amsterdam 73
Seoul 62
Millbury 58
São Paulo 47
Munich 46
Buffalo 42
Redondo Beach 42
Dallas 41
Da Nang 40
Rome 39
Nuremberg 35
Ottawa 35
Boston 33
Des Moines 33
Phoenix 32
Seattle 29
Milan 28
Napoli 28
Orem 26
Lawrence 25
Montreal 25
Lappeenranta 23
Princeton 22
Mexico City 21
Atlanta 20
Brooklyn 20
Haiphong 20
Warsaw 20
Toronto 19
Frankfurt am Main 18
Johannesburg 18
Nanjing 18
Turku 18
Wilmington 16
Houston 15
Manchester 15
Chicago 14
Denver 14
Belo Horizonte 13
Boardman 13
Poplar 13
San Francisco 13
Stockholm 13
Bologna 12
Biên Hòa 11
Helsinki 11
Rio de Janeiro 11
Chennai 10
Querétaro 10
Hải Dương 9
Las Vegas 9
London 9
Long Xuyen 9
Tashkent 9
Vienna 9
Baghdad 8
Brasília 8
Dublin 8
Florence 8
Guangzhou 8
Jiaxing 8
Kochi 8
Nanchang 8
Thái Bình 8
Bengaluru 7
Can Tho 7
Charlotte 7
Mugnano di Napoli 7
Porto Alegre 7
Rochdale 7
San José 7
Washington 7
Bắc Giang 6
Cardito 6
Curitiba 6
Falkenstein 6
Fisciano 6
Ha Long 6
Hebei 6
Kingston 6
Tân Tiến 6
Afragola 5
Totale 5.782
Nome #
Secondary syphilis mimicking malignancy: A case report and review of literature 221
Correction: Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case–control study (SAVALO Study)(BMC Infect Dis., (2024), 24, 1434, 10.1186/s12879-024-10303-5) 190
Guidelines for the Prevention, Diagnosis, and Management of Urinary Tract Infections in Pediatrics and Adults 190
Efficacy of Molnupiravir in Reducing the Risk of Severe Outcomes in Patients with SARS-CoV-2 Infection: A Real-Life Full-Matched Case–Control Study (SAVALO Study) 181
Hepatitis C screening in the Emergency Department of a large hospital in southern Italy: results of a pilot study 176
Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy 172
The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C 164
The Use of Tocilizumab in Patients with COVID-19: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Studies 164
Diabetes Mellitus Type 1, Latent Autoimmune Diabetes of Adults and Hepatitis C Virus: What we Know and what we Need to Know 159
Are third-generation cephalosporins still the empirical antibiotic treatment of community-acquired spontaneous bacterial peritonitis? A systematic review and meta-analysis 149
Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art 148
Impact of oral antiviral therapy against HCV on gut microbiota. A prospective study 145
Vitamin D deficiency is an independent risk factor and is predictor of infections in patients affected by HCV-related liver cirrhosis 144
Novel strategies for the management of bacterial and fungal infections in patients with liver cirrhosis: focus on new antimicrobials 140
Bacteremic nosocomial pneumonia caused by Gram-negative bacilli: results from the nationwide ALARICO study in Italy 138
Beclabuvir for the treatment of hepatitis C 138
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience 136
COVID-19 Post-Exposure Evaluation (COPE) Study: Assessing the Role of Socio-Economic Factors in Household SARS-CoV-2 Transmission within Campania Region (Southern Italy) 135
Risk of professional accidental exposure to biological agents in health care workers: a retrospective analysis carried out in a southern Italian tertiary hospital 135
Update on infective complications in patients treated with alemtuzumab for multiple sclerosis: review and meta-analysis of real-world and randomized studies 135
Efficacy and safety of a fixed dose combination tablet of asunaprevir + beclabuvir + daclatasvir for the treatment of Hepatitis C 134
Unsolved issues in the treatment of spontaneous peritonitis in patients with cirrhosis: Nosocomial versus community-acquired infections and the role of fungi 132
Postvaccination SARS-CoV-2 Infections among Healthcare Professionals: A Real World Evidence Study 131
CEFTO-CURE study: CEFTObiprole Clinical Use in Real-lifE – a multi-centre experience in Italy 131
A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients 131
Efficacy of the "first wave" Direct Acting antivirals against HCV infection: results from the Italian LINA (Liver Network Activity) cohort 130
Appropriateness of antibiotic prescription for targeted therapy of infections caused by multidrug-resistant bacteria: Assessment of the most common improper uses in a tertiary hospital in Southern Italy 129
Efficacy of ultra-short single agent regimen antibiotic chemo-prophylaxis in reducing the risk of meningitis in patients undergoing endoscopic endonasal transsphenoidal surgery 127
Is anticoagulation with novel oral anticoagulants an effective treatment for tuberculosis patients not achieving a therapeutic range with vitamin k antagonists? A Systematic Review 125
Epidemiology, aetiology and treatment of skin and soft tissue infections: final report of a prospective multicentre national registry 124
Measles in pregnant women: A systematic review of clinical outcomes and a meta-analysis of antibodies seroprevalence 123
Current and emerging pharmacotherapy for the treatment of bacterial peritonitis 123
Efficacy and safety of ceftolozane/tazobactam as therapeutic option for complicated skin and soft tissue infections by MDR/XDR Pseudomonas aeruginosa in patients with impaired renal function: a case series from a single-center experience 123
Monoclonal Antibodies against SARS-CoV-2: Potential Game-Changer Still Underused 122
Nosocomial spontaneous bacterial peritonitis antibiotic treatment in the era of multi-drug resistance pathogens: A systematic review 121
Fecal microbiota transplantation for Clostridium difficile infection: Back to the future 120
Limiting the access to direct-acting antivirals against HCV: an ethical dilemma 119
Current evidence on the management of hepatitis B in pregnancy 118
The therapeutic potential of new investigational hepatitis C virus translation inhibitors 117
Spontaneous peritonitis in critically ill cirrhotic patients: a diagnostic algorithm for clinicians and future perspectives 114
Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network) 113
Daptomycin versus vancomycin for the treatment of methicillin-resistant staphylococcus aureus bloodstream infection with or without endocarditis: A systematic review and meta-analysis 113
Hepatitis B mother-to-child transmission and infants immunization: we have not come to the end of the story yet 112
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) 111
Real-world efficacy and safety of pangenotypic direct-acting antivirals against hepatitis C virus infection 111
A rare association of liver abscess and rhabdomyolysis induced by Klebsiella oxytoca 111
Current concepts and future strategies in the antimicrobial therapy of emerging Gram-positive spontaneous bacterial peritonitis 110
Stenotrophomonas maltophilia Infections: A Systematic Review and Meta-Analysis of Comparative Efficacy of Available Treatments, with Critical Assessment of Novel Therapeutic Options 108
The revival of aztreonam in combination with avibactam against metallo-β-lactamase-producing gram-negatives: A systematic review of in vitro studies and clinical cases 107
Epidemiology and Microbiology of Skin and Soft Tissue Infections: Preliminary Results of a National Registry 105
What is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam? 104
Epidemiology, Mechanisms of Resistance and Treatment Algorithm for Infections Due to Carbapenem-Resistant Gram-Negative Bacteria: An Expert Panel Opinion 99
Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience 99
Anaerobic bloodstream infections in Italy (ITANAEROBY): A 5-year retrospective nationwide survey 97
Incidence and prognosis of ventilator-associated pneumonia in critically ill patients with covid-19: A multicenter study 96
The Impact of Carbapenem Resistance on Mortality in Patients With Klebsiella Pneumoniae Bloodstream Infection: An Individual Patient Data Meta-Analysis of 1952 Patients 96
Human Campylobacter spp. infections in Italy 95
NS5B polymerase inhibitors in phase II clinical trials for HCV infection 95
Covid-19: Time for post-exposure prophylaxis? 95
Respiratory Intensive Care Unit management and efficacy during the COVID-19 outbreak in Naples, Italy 94
Safety of hydroxychloroquine for treatment or prevention of SARS-CoV-2 infection: A rapid systematic review and meta-analysis of randomized clinical trials 93
A Response to: Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) 92
Re: Persistent COVID-19 in immunocompromised patients-Israeli Society of Infectious Diseases consensus statement on diagnosis and management by Meijer et al 87
Does early combination vs. Monotherapy improve clinical outcomes of clinically extremely vulnerable patients with COVID-19? Results from a retrospective propensity-weighted analysis 87
A systematic review on the effect of diabetes mellitus on the pharmacokinetics of TB drugs 85
A subanalysis of Clostridium perfringens bloodstream infections from a 5-year retrospective nationwide survey (ITANAEROBY) 85
Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) 83
Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM) 83
Oral Vancomycin Prophylaxis for Primary and Secondary Prevention of Clostridioides difficile Infection in Patients Treated with Systemic Antibiotic Therapy: A Systematic Review, Meta-Analysis and Trial Sequential Analysis 83
Fosfomycin as partner drug for systemic infection management. a systematic review of its synergistic properties from in vitro and in vivo studies 82
Prevention of hepatitis B virus infection: from the past to the future 82
SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis 81
Intravenous Fosfomycin for Systemic Multidrug-Resistant Pseudomonas aeruginosa Infections 81
Liver fungal infections: An overview of the etiology and epidemiology in patients affected or not affected by oncohematologic malignancies 78
Fosfomycin in continuous or prolonged infusion for systemic bacterial infections: a systematic review of its dosing regimen proposal from in vitro, in vivo and clinical studies 77
Clinical Efficacy of Ceftolozane-Tazobactam Versus Other Active Agents for the Treatment of Bacteremia and Nosocomial Pneumonia due to Drug-Resistant Pseudomonas aeruginosa 76
Ceftolozane/tazobactam for difficult-to-treat Pseudomonas aeruginosa infections: A systematic review of its efficacy and safety for off-label indications 76
Personal life and working conditions of trainees and young specialists in clinical microbiology and infectious diseases in Europe: a questionnaire survey 75
Predisposing factor, impactful adjunctive treatment or unfavorable prognostic marker: a meta-analysis on the elusive role of dexamethasone for Listeria monocytogenes meningitis. 75
Carbapenem-sparing strategy: carbapenemase, treatment, and stewardship 75
Use of colistin in adult patients: A cross-sectional study 74
Colistin plus meropenem versus colistin alone for invasive infections caused by carbapenem-resistant Acinetobacter baumannii: a rapid systematic review of randomized controlled trials using Bayesian meta-analysis 72
Short Course Antibiotic Therapy for Catheter-Related Septic Thrombosis: “Caveat Emptor!”: Duration of Therapy Should Not Be Set a Priori 72
Management of chickenpox in pregnant women: an Italian perspective 71
Resistance to ceftazidime/avibactam in infections and colonisations by KPC-producing Enterobacterales: a systematic review of observational clinical studies 65
Extended Infusion of β-Lactams for Bloodstream Infection in Patients With Liver Cirrhosis: An Observational Multicenter Study 65
Letter: The potential success of long-term therapy of chronic delta hepatitis with peginterferon alfa 65
Editorial for the Special Issue: “The Issue of Multidrug-Resistant Pathogens in Nosocomial Infections” 64
Organization and training at national level of antimicrobial stewardship and infection control activities in Europe: an ESCMID cross-sectional survey 59
The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission—a living systematic review 58
What do we know About the Usefulness of 18F-FDG PET-CT for the Management of Invasive Fungal Infection? An International Survey 58
Risk factors for candidaemia in hospitalized patients with liver cirrhosis: a multicentre case–control–control study 58
Changes in the relative prevalence of candidaemia due to non-albicans Candida species in adult in-patients: A systematic review, meta-analysis and meta-regression 58
Response to: ‘Letter to the Editor: “Management of multidrug-resistant Pseudomonas aeruginosa in the Intensive Care Unit: state of the art”’ 56
Editorial: Viral Infections in the Intensive Care Unit 54
Kaposi sarcoma and vertebral involvement in people with HIV: a case report and systematic literature review 54
Remdesivir-Induced Bradycardia in COVID-19: A Single Center Prospective Study 53
Risk factors for candidemia after open heart surgery: Results from a multicenter case-control study 51
Editorial for the Special Issue: “Current and Novel Antimicrobial Strategies for Bacterial and Fungal Infections by Resistant Organisms” 45
Which trials do we need? Fidaxomicin plus either intravenous metronidazole or tigecycline versus vancomycin plus either intravenous metronidazole or tigecycline for fulminant Clostridioides difficile infection 44
Totale 10.557
Categoria #
all - tutte 34.214
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.214


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022248 0 0 1 1 0 4 1 9 33 12 71 116
2022/2023382 48 31 19 24 31 36 1 39 54 64 26 9
2023/2024272 13 50 38 13 24 32 7 24 2 2 43 24
2024/20252.642 62 59 64 105 97 132 319 172 178 262 916 276
2025/20266.237 581 607 614 650 913 284 591 456 580 341 307 313
2026/2027639 131 316 192 0 0 0 0 0 0 0 0 0
Totale 10.773